Certior Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$590K Sell
2,346
-133
-5% -$28.6K 0.32% 61
2026
Q1
$539K Buy
2,479
+87
+4% +$19.3K 0.34% 56
2025
Q4
$547K Sell
2,392
-163
-6% -$37.1K 0.37% 53
2025
Q3
$592K Sell
2,555
-197
-7% -$40.1K 0.39% 53
2025
Q2
$511K Buy
2,752
+125
+5% +$23.2K 0.38% 54
2025
Q1
$550K Buy
2,627
+100
+4% +$19.4K 0.45% 49
2024
Q4
$449K Buy
+2,527
New +$465K 0.39% 63

Other funds holding ABBV

Certior Financial Group's ABBV Position: Q2 2026 in Review

Certior Financial Group reduced its AbbVie (ABBV) stake by 5.4% in Q2 2026, selling an estimated $28.6K and leaving 2,346 shares worth $590K. The position accounts for 0.32% of the portfolio, ranked #61.

Certior Financial Group first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $592K in Q3 2025. 1,884 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Certior Financial Group held 2,346 shares of AbbVie worth $590K as of Q2 2026.
  • Certior Financial Group sold 133 AbbVie shares in Q2 2026, an estimated $28.6K.
  • AbbVie made up 0.32% of Certior Financial Group's portfolio in Q2 2026, its #61 holding.
  • Certior Financial Group first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Certior Financial Group's AbbVie position peaked at $592K in Q3 2025.
  • 1,884 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Certior Financial Group's 13F filing for Q2 2026, filed 20 Jul 2026.